Resource item

Item 9 Labs Corp. will present at major investor conferences in April

Franchisor and Operator of Vertically Integrated Cannabis Dispensary to Share Recent Positive Momentum for Accelerated National Growth in 2022

PHOENIX, April 5, 2022 /PRNewswire/ — Article 9 Labs Corp. INLB (the “Company”) – a vertically integrated cannabis dispensary franchisor and operator that manufactures premium, award-winning products – today announced that the Company’s management team will be participating in several investor events in April. These events include: Noble Capital Markets 18th Annual Small & Micro Capacity Investor Conference (NobleCon18), Sequire’s Virtual Cannabis & Psychedelic Conference and Benzinga’s Spring Cannabis Capital Conference.

INLB is a vertically integrated cannabis franchisor and operator headquartered in Arizona that manufactures premium, award-winning products. With deep experience in cannabis, franchising and financial markets, the company brings industry best practices to national markets through a distinctive retail experience, cultivation capabilities and innovation. of products. (PRNewsfoto/Item 9 Labs Corp.)” alt=”Item 9 Labs Corp. INLB is a vertically integrated cannabis franchisor and operator headquartered in Arizona that manufactures premium, award-winning products. With deep experience in cannabis, franchising and financial markets, the company brings industry best practices to national markets through a distinctive retail experience, cultivation capabilities and innovation. of products. (PRNewsphoto/Item 9 Labs Corp.)”>

The management team of Item 9 Labs Corp. will feature the three main investor events and provide an in-depth overview of the company, highlighting its key differentiators in the cannabis space. Additionally, they will be sharing updates on its cultivation expansion in Arizona and Nevada as well as recent acquisition activity and expansion of its dispensary franchise, Unity Rd., into new state markets. Attendees will also learn about the accelerated momentum of its award-winning cannabis brand, Item 9 Labs, and the latest product innovations.

The Company’s Chief Financial Officer, Bobby Mikkelsen; franchise manager, Michael Weinberger; and Chief Operating Officer, Chris Wolf will be on hand at NobleCon18 and the Benzinga conference and is currently accepting in-person meetings with potential shareholders and investors in one-on-one sessions throughout the events. Register for meetings through the event platform or contact [email protected] to coordinate.

NobleCon18 Small & Micro Cap Investor Conference

  • Date of presentation: Wednesday April 20
  • Presentation Time: 9:30 a.m. ET
  • Location: Hard Rock Guitar Hotel in Miami Gardens/Hollywood, Florida
  • Registration: Those interested in attending the presentation can register here.

Sequire Cannabis and Psychedelics Virtual Conference

  • Date of presentation: Wednesday, April 20, 2022
  • Presentation time: 9 a.m. ET
  • Registration: Those interested in seeing the presentation can register here.

Benzinga Spring Cannabis Capital Conference

  • Date of presentation: Thursday, April 21, 2022
  • Presentation time: 1:50 p.m. ET
  • Location: Fontainebleau Miami Beach, Florida
  • Registration: Those interested in attending the presentation can register here.

For more information on Item 9 Labs Corp. and its marks, visit https://investors.item9labscorp.com/.

About Item 9 Labs Corp.
Section 9 Labs Corp. INLB is a vertically integrated cannabis operator and dispensary franchisor that offers premium products from its large-scale cultivation and production facilities in the United States. Award-winning brand Item 9 Labs specializes in the best products and user experience across multiple cannabis categories. The company also offers a unique dispensary franchise model through the nationwide Unity Rd. retail brand. By lowering barriers to entry, franchising provides an opportunity for new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings industry best practices to markets nationwide through a distinctive retail experience, culture capabilities and product innovation. The seasoned management team combines a diverse skill set with deep experience in the cannabis industry, franchising and capital markets to lead a new generation of public cannabis companies that deliver transparency, consistency and well-being. Based in Arizona, the company is currently expanding its operating space up to 640,000 square feet on its 50-acre site, one of the largest properties in Arizona zoned for growing and growing flowers. For more information, visit item9labscorp.com.

Forward-looking statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, including, but not limited to, the risks and effects of judicial and administrative proceedings and governmental proceedings. regulation, particularly in a foreign country, future financial and operating results, competition, general economic conditions, proposed transactions that are not legally binding on the company and the ability to manage and pursue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this press release include the introduction of new technologies, market conditions and those set forth in any reports or documents we file from time to time. another with the SEC. We undertake no obligation to revise or update these statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unforeseen events.

Media Contact:
Section 9 Labs Corp.
Jayne Levyvice president of communications
Phone: 480-542-9421
Email: [email protected]

Investor contacts:
Section 9 Labs Corp.
Phone: 800-403-1140
Email: [email protected]

Quote View original content to download multimedia: https://www.prnewswire.com/news-releases/item-9-labs-corp-to-present-at-leading-investor-conferences-in-april-301517851.html

SOURCE Element 9 Labs Corp.